[Xenogeneic splenic perfusion in the treatment of bronchial asthma patients].
Blood morphology, external respiratory function, central hemodynamics, cellular and humoral immunity, circulating immune complexes, average molecules and leucocytic index were examined in 40 patients with a severe and average severe course of infection-dependent bronchial asthma before and after xenosplenoperfusion. Positive clinical results were noted manifested in an increase of the immune reactivity, improvement of external respiratory function. The method should be used with care due to additional sensibilization of the patient and possible bronchospasm.
Lazarev
V N
VN
Karashurov
E S
ES
Ostrovskiĭ
A G
AG
Putkaradze
T A
TA
Markelov
Iu M
IuM
Karashurov
S E
SE
Tsypin
A B
AB
Vedernikova
L A
LA
D000328:Adult; D000917:Antibody Formation; D001249:Asthma / Q000097:blood / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D003427:Cross Circulation; D006439:Hemodynamics; D006801:Humans; D007111:Immunity, Cellular; D007958:Leukocyte Count; D010477:Perfusion; D012129:Respiratory Function Tests; D013154:Spleen / Q000098:blood supply*; D013997:Time Factors
Ksenosplenoperfuziia v lechenii bol'nykh bronkhial'noĭ astmoĭ.